edited by John C. Bloom
Presenting recent applications in clinical development, pharmacokinetic/ pharmacodynamic modeling, and clinical trial simulation, this in-depth reference studies the role of biomarkers in successful drug formulation and development—utilizing the latest discoveries in biomarker science to determine the safety and efficacy of emerging drug compounds.
Contents
- Biomarkers in clinical Drug Development: Definitions and Disciplines
- The Clinical Laboratory and Collection of Biomarker Data
- Using Imaging Biomarkers to Demonstrate Efficacy in Clinical Trials: trends and Challenges
- Markers for Cardiac Repolarization and Risk Assessment
- Development and Application of Interspecies Biomarkers in Nonclinical Safety Evaluations
- Validation of Assays for the Bioanalysis of Novel Biomarkers: Practical Recommendations for Clinical Investigation of New Drug Entities
- Validation of Biomarkers as Surrogates for Clinical Endpoints
- Biomarkers in Pharmacokinetic/Pharmacodynamic Modeling and Clinical Trial Simulation
- Pharmacogenomic Biomarkers
- Quality Assurace and Regulatory Compliance
- Biomarkers Strategies in Drug Development: Striking a Balance Between Opportunities and Liabilities
- Partnerships on Biomarker Research
- Clinical Operations: Business Principles for Biomarker Applications
Index